Global Drug-Loadable Embolic Microspheres Market Research Report 2026(Status and Outlook)

February 2026 | 146 pages | ID: GBEC910765A8EN
Bosson Research

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug-Loadable Embolic Microspheres competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Drug-loadable embolic microsphere is a therapeutic embolic agent used to block tumor blood flow and drug delivery. Loadable embolic microspheres delivered by transarterial chemoembolization (TACE) serve as a therapeutic embolic to stop blood flow to tumors and a drug delivery vehicle.In 2024, global Drug-loadable embolic microsphere production reached approximately 1067 L, with an average global market price of around US$1300 per mL. The single-line production capacity for drug-loadable embolic microspheres is approximately 20-100 liters/year. The industry's gross profit margin is approximately 60% to 80%. Raw materials (polymers such as PVA and drugs) account for the largest portion of the cost structure, approximately 30% to 40%, with the remainder comprising production consumables and packaging materials, labor costs, and manufacturing expenses. Upstream raw material suppliers provide key raw materials such as biodegradable polymers and drug-loaded materials; downstream players primarily include hospitals and medical institutions (as end users, performing TACE treatments) and dealers and distributors (responsible for regional product sales and promotion).The drug-loadable embolic microsphere segment is maturing from a niche adjunct to a core interventional oncology platform that couples mechanical occlusion with localized pharmacotherapy. Advances in polymer science and controlled-release formulation have improved particle uniformity and intratumoral drug delivery predictability, which enhances procedural reproducibility and clinician confidence. Broad clinical adoption depends less on incremental device features than on robust clinical evidence and regulatory clarity; products backed by multicenter studies and clear procedural protocols are more likely to be integrated into standard care pathways. Manufacturing reliability?consistent batch-to-batch performance, scalable production, and stringent quality systems?is a critical commercial differentiator, since clinicians and hospitals prioritize devices with dependable supply and consistent behavior. Cost and accessibility remain meaningful constraints in lower-resource settings, preserving a role for simpler embolics even as high-value drug-eluting platforms gain ground in advanced centers. Strategically, winners will be those combining differentiated drug-delivery chemistry, demonstrable clinical benefit, and pragmatic manufacturing scale-up, enabling integration with image-guided workflows and personalized therapeutic strategies.

The global Drug-Loadable Embolic Microspheres market size was estimated at USD 1387.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.70% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Drug-Loadable Embolic Microspheres market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Drug-Loadable Embolic Microspheres market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug-Loadable Embolic Microspheres market.

Global Drug-Loadable Embolic Microspheres Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Boston Scientific
Terumo
Merit Medical
Varian
Sirtex Medical
Suzhou Hengrui Medical Equipment
ABK Biomedical
Mermaid Medical
Cardiolink Science
Suzhou Haowei Medical Technology

Market Segmentation (by Type)

Drug-eluting Microspheres
Radioactive Microspheres

Market Segmentation (by Application)

Primary Liver Cancer
Colorectal Cancer Liver Metastasis
Others

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug-Loadable Embolic Microspheres Market
Overview of the regional outlook of the Drug-Loadable Embolic Microspheres Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Loadable Embolic Microspheres Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Drug-Loadable Embolic Microspheres, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Drug-Loadable Embolic Microspheres
1.2 Key Market Segments
  1.2.1 Drug-Loadable Embolic Microspheres Segment by Type
  1.2.2 Drug-Loadable Embolic Microspheres Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 DRUG-LOADABLE EMBOLIC MICROSPHERES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Drug-Loadable Embolic Microspheres Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Drug-Loadable Embolic Microspheres Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 DRUG-LOADABLE EMBOLIC MICROSPHERES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Drug-Loadable Embolic Microspheres Product Life Cycle
3.3 Global Drug-Loadable Embolic Microspheres Sales by Manufacturers (2020-2025)
3.4 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug-Loadable Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug-Loadable Embolic Microspheres Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Drug-Loadable Embolic Microspheres Market Competitive Situation and Trends
  3.8.1 Drug-Loadable Embolic Microspheres Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Drug-Loadable Embolic Microspheres Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 DRUG-LOADABLE EMBOLIC MICROSPHERES INDUSTRY CHAIN ANALYSIS

4.1 Drug-Loadable Embolic Microspheres Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF DRUG-LOADABLE EMBOLIC MICROSPHERES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Drug-Loadable Embolic Microspheres Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Drug-Loadable Embolic Microspheres Market
5.7 ESG Ratings of Leading Companies

6 DRUG-LOADABLE EMBOLIC MICROSPHERES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2020-2025)
6.3 Global Drug-Loadable Embolic Microspheres Market Size by Type (2020-2025)
6.4 Global Drug-Loadable Embolic Microspheres Price by Type (2020-2025)

7 DRUG-LOADABLE EMBOLIC MICROSPHERES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Loadable Embolic Microspheres Market Sales by Application (2020-2025)
7.3 Global Drug-Loadable Embolic Microspheres Market Size (M USD) by Application (2020-2025)
7.4 Global Drug-Loadable Embolic Microspheres Sales Growth Rate by Application (2020-2025)

8 DRUG-LOADABLE EMBOLIC MICROSPHERES MARKET SALES BY REGION

8.1 Global Drug-Loadable Embolic Microspheres Sales by Region
  8.1.1 Global Drug-Loadable Embolic Microspheres Sales by Region
  8.1.2 Global Drug-Loadable Embolic Microspheres Sales Market Share by Region
8.2 Global Drug-Loadable Embolic Microspheres Market Size by Region
  8.2.1 Global Drug-Loadable Embolic Microspheres Market Size by Region
  8.2.2 Global Drug-Loadable Embolic Microspheres Market Size by Region
8.3 North America
  8.3.1 North America Drug-Loadable Embolic Microspheres Sales by Country
  8.3.2 North America Drug-Loadable Embolic Microspheres Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Drug-Loadable Embolic Microspheres Sales by Country
  8.4.2 Europe Drug-Loadable Embolic Microspheres Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Drug-Loadable Embolic Microspheres Sales by Region
  8.5.2 Asia Pacific Drug-Loadable Embolic Microspheres Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Drug-Loadable Embolic Microspheres Sales by Country
  8.6.2 South America Drug-Loadable Embolic Microspheres Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Drug-Loadable Embolic Microspheres Sales by Region
  8.7.2 Middle East and Africa Drug-Loadable Embolic Microspheres Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 DRUG-LOADABLE EMBOLIC MICROSPHERES MARKET PRODUCTION BY REGION

9.1 Global Production of Drug-Loadable Embolic Microspheres by Region(2020-2025)
9.2 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2020-2025)
9.3 Global Drug-Loadable Embolic Microspheres Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug-Loadable Embolic Microspheres Production
  9.4.1 North America Drug-Loadable Embolic Microspheres Production Growth Rate (2020-2025)
  9.4.2 North America Drug-Loadable Embolic Microspheres Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug-Loadable Embolic Microspheres Production
  9.5.1 Europe Drug-Loadable Embolic Microspheres Production Growth Rate (2020-2025)
  9.5.2 Europe Drug-Loadable Embolic Microspheres Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug-Loadable Embolic Microspheres Production (2020-2025)
  9.6.1 Japan Drug-Loadable Embolic Microspheres Production Growth Rate (2020-2025)
  9.6.2 Japan Drug-Loadable Embolic Microspheres Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug-Loadable Embolic Microspheres Production (2020-2025)
  9.7.1 China Drug-Loadable Embolic Microspheres Production Growth Rate (2020-2025)
  9.7.2 China Drug-Loadable Embolic Microspheres Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Boston Scientific
  10.1.1 Boston Scientific Basic Information
  10.1.2 Boston Scientific Drug-Loadable Embolic Microspheres Product Overview
  10.1.3 Boston Scientific Drug-Loadable Embolic Microspheres Product Market Performance
  10.1.4 Boston Scientific Business Overview
  10.1.5 Boston Scientific SWOT Analysis
  10.1.6 Boston Scientific Recent Developments
10.2 Terumo
  10.2.1 Terumo Basic Information
  10.2.2 Terumo Drug-Loadable Embolic Microspheres Product Overview
  10.2.3 Terumo Drug-Loadable Embolic Microspheres Product Market Performance
  10.2.4 Terumo Business Overview
  10.2.5 Terumo SWOT Analysis
  10.2.6 Terumo Recent Developments
10.3 Merit Medical
  10.3.1 Merit Medical Basic Information
  10.3.2 Merit Medical Drug-Loadable Embolic Microspheres Product Overview
  10.3.3 Merit Medical Drug-Loadable Embolic Microspheres Product Market Performance
  10.3.4 Merit Medical Business Overview
  10.3.5 Merit Medical SWOT Analysis
  10.3.6 Merit Medical Recent Developments
10.4 Varian
  10.4.1 Varian Basic Information
  10.4.2 Varian Drug-Loadable Embolic Microspheres Product Overview
  10.4.3 Varian Drug-Loadable Embolic Microspheres Product Market Performance
  10.4.4 Varian Business Overview
  10.4.5 Varian Recent Developments
10.5 Sirtex Medical
  10.5.1 Sirtex Medical Basic Information
  10.5.2 Sirtex Medical Drug-Loadable Embolic Microspheres Product Overview
  10.5.3 Sirtex Medical Drug-Loadable Embolic Microspheres Product Market Performance
  10.5.4 Sirtex Medical Business Overview
  10.5.5 Sirtex Medical Recent Developments
10.6 Suzhou Hengrui Medical Equipment
  10.6.1 Suzhou Hengrui Medical Equipment Basic Information
  10.6.2 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Overview
  10.6.3 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Market Performance
  10.6.4 Suzhou Hengrui Medical Equipment Business Overview
  10.6.5 Suzhou Hengrui Medical Equipment Recent Developments
10.7 ABK Biomedical
  10.7.1 ABK Biomedical Basic Information
  10.7.2 ABK Biomedical Drug-Loadable Embolic Microspheres Product Overview
  10.7.3 ABK Biomedical Drug-Loadable Embolic Microspheres Product Market Performance
  10.7.4 ABK Biomedical Business Overview
  10.7.5 ABK Biomedical Recent Developments
10.8 Mermaid Medical
  10.8.1 Mermaid Medical Basic Information
  10.8.2 Mermaid Medical Drug-Loadable Embolic Microspheres Product Overview
  10.8.3 Mermaid Medical Drug-Loadable Embolic Microspheres Product Market Performance
  10.8.4 Mermaid Medical Business Overview
  10.8.5 Mermaid Medical Recent Developments
10.9 Cardiolink Science
  10.9.1 Cardiolink Science Basic Information
  10.9.2 Cardiolink Science Drug-Loadable Embolic Microspheres Product Overview
  10.9.3 Cardiolink Science Drug-Loadable Embolic Microspheres Product Market Performance
  10.9.4 Cardiolink Science Business Overview
  10.9.5 Cardiolink Science Recent Developments
10.10 Suzhou Haowei Medical Technology
  10.10.1 Suzhou Haowei Medical Technology Basic Information
  10.10.2 Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Product Overview
  10.10.3 Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Product Market Performance
  10.10.4 Suzhou Haowei Medical Technology Business Overview
  10.10.5 Suzhou Haowei Medical Technology Recent Developments

11 DRUG-LOADABLE EMBOLIC MICROSPHERES MARKET FORECAST BY REGION

11.1 Global Drug-Loadable Embolic Microspheres Market Size Forecast
11.2 Global Drug-Loadable Embolic Microspheres Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Drug-Loadable Embolic Microspheres Market Size Forecast by Country
  11.2.3 Asia Pacific Drug-Loadable Embolic Microspheres Market Size Forecast by Region
  11.2.4 South America Drug-Loadable Embolic Microspheres Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Drug-Loadable Embolic Microspheres by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Drug-Loadable Embolic Microspheres Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Drug-Loadable Embolic Microspheres by Type (2026-2035)
  12.1.2 Global Drug-Loadable Embolic Microspheres Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Drug-Loadable Embolic Microspheres by Type (2026-2035)
12.2 Global Drug-Loadable Embolic Microspheres Market Forecast by Application (2026-2035)
  12.2.1 Global Drug-Loadable Embolic Microspheres Sales (K MT) Forecast by Application
  12.2.2 Global Drug-Loadable Embolic Microspheres Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug-Loadable Embolic Microspheres Market Size by Type (M USD)
Table 4. Global Drug-Loadable Embolic Microspheres Market Size by Application
Table 5. Drug-Loadable Embolic Microspheres Market Size Comparison by Region (M USD)
Table 6. Global Drug-Loadable Embolic Microspheres Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Drug-Loadable Embolic Microspheres Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drug-Loadable Embolic Microspheres Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Drug-Loadable Embolic Microspheres Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Loadable Embolic Microspheres as of 2025)
Table 11. Global Market Drug-Loadable Embolic Microspheres Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Drug-Loadable Embolic Microspheres Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug-Loadable Embolic Microspheres Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Drug-Loadable Embolic Microspheres Sales by Type (K MT)
Table 27. Global Drug-Loadable Embolic Microspheres Market Size by Type (M USD)
Table 28. Global Drug-Loadable Embolic Microspheres Sales (K MT) by Type (2020-2025)
Table 29. Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2020-2025)
Table 30. Global Drug-Loadable Embolic Microspheres Market Size (M USD) by Type (2020-2025)
Table 31. Global Drug-Loadable Embolic Microspheres Market Share by Type (2020-2025)
Table 32. Global Drug-Loadable Embolic Microspheres Price (USD/KG) by Type (2020-2025)
Table 33. Global Drug-Loadable Embolic Microspheres Sales (K MT) by Application
Table 34. Global Drug-Loadable Embolic Microspheres Market Size by Application
Table 35. Global Drug-Loadable Embolic Microspheres Sales by Application (2020-2025) & (K MT)
Table 36. Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2020-2025)
Table 37. Global Drug-Loadable Embolic Microspheres Market Size by Application (2020-2025) & (M USD)
Table 38. Global Drug-Loadable Embolic Microspheres Market Share by Application (2020-2025)
Table 39. Global Drug-Loadable Embolic Microspheres Sales Growth Rate by Application (2020-2025)
Table 40. Global Drug-Loadable Embolic Microspheres Sales by Region (2020-2025) & (K MT)
Table 41. Global Drug-Loadable Embolic Microspheres Sales Market Share by Region (2020-2025)
Table 42. Global Drug-Loadable Embolic Microspheres Market Size by Region (2020-2025) & (M USD)
Table 43. Global Drug-Loadable Embolic Microspheres Market Size by Region (2020-2025)
Table 44. North America Drug-Loadable Embolic Microspheres Sales by Country (2020-2025) & (K MT)
Table 45. North America Drug-Loadable Embolic Microspheres Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Drug-Loadable Embolic Microspheres Sales by Country (2020-2025) & (K MT)
Table 47. Europe Drug-Loadable Embolic Microspheres Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Drug-Loadable Embolic Microspheres Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Drug-Loadable Embolic Microspheres Market Size by Region (2020-2025) & (M USD)
Table 50. South America Drug-Loadable Embolic Microspheres Sales by Country (2020-2025) & (K MT)
Table 51. South America Drug-Loadable Embolic Microspheres Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Drug-Loadable Embolic Microspheres Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Drug-Loadable Embolic Microspheres Market Size by Region (2020-2025) & (M USD)
Table 54. Global Drug-Loadable Embolic Microspheres Production (K MT) by Region(2020-2025)
Table 55. Global Drug-Loadable Embolic Microspheres Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2020-2025)
Table 57. Global Drug-Loadable Embolic Microspheres Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Drug-Loadable Embolic Microspheres Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Drug-Loadable Embolic Microspheres Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Drug-Loadable Embolic Microspheres Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Drug-Loadable Embolic Microspheres Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Boston Scientific Basic Information
Table 63. Boston Scientific Drug-Loadable Embolic Microspheres Product Overview
Table 64. Boston Scientific Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Boston Scientific Business Overview
Table 66. Boston Scientific SWOT Analysis
Table 67. Boston Scientific Recent Developments
Table 68. Terumo Basic Information
Table 69. Terumo Drug-Loadable Embolic Microspheres Product Overview
Table 70. Terumo Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Terumo Business Overview
Table 72. Terumo SWOT Analysis
Table 73. Terumo Recent Developments
Table 74. Merit Medical Basic Information
Table 75. Merit Medical Drug-Loadable Embolic Microspheres Product Overview
Table 76. Merit Medical Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Merit Medical Business Overview
Table 78. Merit Medical SWOT Analysis
Table 79. Merit Medical Recent Developments
Table 80. Varian Basic Information
Table 81. Varian Drug-Loadable Embolic Microspheres Product Overview
Table 82. Varian Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Varian Business Overview
Table 84. Varian Recent Developments
Table 85. Sirtex Medical Basic Information
Table 86. Sirtex Medical Drug-Loadable Embolic Microspheres Product Overview
Table 87. Sirtex Medical Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sirtex Medical Business Overview
Table 89. Sirtex Medical Recent Developments
Table 90. Suzhou Hengrui Medical Equipment Basic Information
Table 91. Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Overview
Table 92. Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Suzhou Hengrui Medical Equipment Business Overview
Table 94. Suzhou Hengrui Medical Equipment Recent Developments
Table 95. ABK Biomedical Basic Information
Table 96. ABK Biomedical Drug-Loadable Embolic Microspheres Product Overview
Table 97. ABK Biomedical Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. ABK Biomedical Business Overview
Table 99. ABK Biomedical Recent Developments
Table 100. Mermaid Medical Basic Information
Table 101. Mermaid Medical Drug-Loadable Embolic Microspheres Product Overview
Table 102. Mermaid Medical Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Mermaid Medical Business Overview
Table 104. Mermaid Medical Recent Developments
Table 105. Cardiolink Science Basic Information
Table 106. Cardiolink Science Drug-Loadable Embolic Microspheres Product Overview
Table 107. Cardiolink Science Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Cardiolink Science Business Overview
Table 109. Cardiolink Science Recent Developments
Table 110. Suzhou Haowei Medical Technology Basic Information
Table 111. Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Product Overview
Table 112. Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Suzhou Haowei Medical Technology Business Overview
Table 114. Suzhou Haowei Medical Technology Recent Developments
Table 115. Global Drug-Loadable Embolic Microspheres Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Drug-Loadable Embolic Microspheres Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Drug-Loadable Embolic Microspheres Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Drug-Loadable Embolic Microspheres Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Drug-Loadable Embolic Microspheres Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Drug-Loadable Embolic Microspheres Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Drug-Loadable Embolic Microspheres Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Drug-Loadable Embolic Microspheres Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Drug-Loadable Embolic Microspheres Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Drug-Loadable Embolic Microspheres Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Drug-Loadable Embolic Microspheres Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Drug-Loadable Embolic Microspheres Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Drug-Loadable Embolic Microspheres Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Drug-Loadable Embolic Microspheres Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Drug-Loadable Embolic Microspheres Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Drug-Loadable Embolic Microspheres Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Drug-Loadable Embolic Microspheres Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Drug-Loadable Embolic Microspheres
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Loadable Embolic Microspheres Market Size (M USD), 2025-2035
Figure 5. Global Drug-Loadable Embolic Microspheres Market Size (M USD) (2020-2035)
Figure 6. Global Drug-Loadable Embolic Microspheres Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Loadable Embolic Microspheres Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug-Loadable Embolic Microspheres Product Life Cycle
Figure 13. Drug-Loadable Embolic Microspheres Sales Share by Manufacturers in 2025
Figure 14. Global Drug-Loadable Embolic Microspheres Revenue Share by Manufacturers in 2025
Figure 15. Drug-Loadable Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Drug-Loadable Embolic Microspheres Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug-Loadable Embolic Microspheres Revenue in 2025
Figure 18. Industry Chain Map of Drug-Loadable Embolic Microspheres
Figure 19. Global Drug-Loadable Embolic Microspheres Market PEST Analysis
Figure 20. Global Drug-Loadable Embolic Microspheres Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drug-Loadable Embolic Microspheres Market Share by Type
Figure 27. Sales Market Share of Drug-Loadable Embolic Microspheres by Type (2020-2025)
Figure 28. Sales Market Share of Drug-Loadable Embolic Microspheres by Type in 2025
Figure 29. Market Share of Drug-Loadable Embolic Microspheres by Type (2020-2025)
Figure 30. Market Share of Drug-Loadable Embolic Microspheres by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drug-Loadable Embolic Microspheres Market Share by Application
Figure 33. Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2020-2025)
Figure 34. Global Drug-Loadable Embolic Microspheres Sales Market Share by Application in 2025
Figure 35. Global Drug-Loadable Embolic Microspheres Market Share by Application (2020-2025)
Figure 36. Global Drug-Loadable Embolic Microspheres Market Share by Application in 2025
Figure 37. Global Drug-Loadable Embolic Microspheres Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drug-Loadable Embolic Microspheres Sales Market Share by Region (2020-2025)
Figure 39. Global Drug-Loadable Embolic Microspheres Market Size by Region (2020-2025)
Figure 40. North America Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Drug-Loadable Embolic Microspheres Sales Market Share by Country in 2024
Figure 43. North America Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drug-Loadable Embolic Microspheres Market Size by Country in 2024
Figure 45. U.S. Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drug-Loadable Embolic Microspheres Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Drug-Loadable Embolic Microspheres Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drug-Loadable Embolic Microspheres Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drug-Loadable Embolic Microspheres Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Drug-Loadable Embolic Microspheres Sales Market Share by Country in 2024
Figure 53. Europe Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drug-Loadable Embolic Microspheres Market Size by Country in 2024
Figure 55. Germany Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drug-Loadable Embolic Microspheres Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Drug-Loadable Embolic Microspheres Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drug-Loadable Embolic Microspheres Market Size by Region in 2024
Figure 68. China Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drug-Loadable Embolic Microspheres Sales and Growth Rate (K MT)
Figure 79. South America Drug-Loadable Embolic Microspheres Sales Market Share by Country in 2024
Figure 80. South America Drug-Loadable Embolic Microspheres Market Size and Growth Rate (M USD)
Figure 81. South America Drug-Loadable Embolic Microspheres Market Size by Country in 2024
Figure 82. Brazil Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drug-Loadable Embolic Microspheres Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Drug-Loadable Embolic Microspheres Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drug-Loadable Embolic Microspheres Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drug-Loadable Embolic Microspheres Market Size by Region in 2024
Figure 92. Saudi Arabia Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drug-Loadable Embolic Microspheres Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Drug-Loadable Embolic Microspheres Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drug-Loadable Embolic Microspheres Production Market Share by Region (2020-2025)
Figure 103. North America Drug-Loadable Embolic Microspheres Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Drug-Loadable Embolic Microspheres Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Drug-Loadable Embolic Microspheres Production (K MT) Growth Rate (2020-2025)
Figure 106. China Drug-Loadable Embolic Microspheres Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Drug-Loadable Embolic Microspheres Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Drug-Loadable Embolic Microspheres Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Drug-Loadable Embolic Microspheres Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Drug-Loadable Embolic Microspheres Market Share Forecast by Type (2026-2035)
Figure 111. Global Drug-Loadable Embolic Microspheres Sales Forecast by Application (2026-2035)
Figure 112. Global Drug-Loadable Embolic Microspheres Market Share Forecast by Application (2026-2035)


More Publications